AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
AcelRx Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
AcelRx Pharmaceuticals reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, five executives at AcelRx Pharmaceuticals received on average a compensation package of $1.2M, a 12% increase compared to previous year.
Average pay of disclosed executives at AcelRx Pharmaceuticals
Vincent J. Angotti, Chief Executive Officer, received $2.1M in total, which increased by 22% compared to 2018. 34% of Angotti's compensation, or $727K, was in option awards. Angotti also received $267K in non-equity incentive plan, $618K in salary, $502K in stock awards, as well as $11K in other compensation.
For fiscal year 2019, the median employee pay was $206,159 at AcelRx Pharmaceuticals. Therefore, the ratio of Vincent J. Angotti's pay to the median employee pay was 10 to one.
Pamela P. Palmer, Chief Medical Officer, received a compensation package of $1.1M, which increased by 2% compared to previous year. 44% of the compensation package, or $482K, was in salary.
Raffi Asadorian, Chief Financial Officer, earned $1M in 2019, a 12% increase compared to previous year.
Badri Dasu, Chief Engineering Officer, received $776K in 2019, which increases by 6% compared to 2018.
Lawrence G. Hamel, Former Chief Development Officer, earned $776K in 2019, a 13% increase compared to previous year.
Related executives
Vincent Angotti
AcelRx Pharmaceuticals
Chief Executive Officer
Raffi Asadorian
AcelRx Pharmaceuticals
Chief Financial Officer
Pamela Palmer
AcelRx Pharmaceuticals
Chief Medical Officer
Badri Dasu
AcelRx Pharmaceuticals
Chief Engineering Officer
Lawrence Hamel
AcelRx Pharmaceuticals
Former Chief Development Officer
You may also like
Source: SEC filing on April 24, 2020.